Follow
Aleksandrs Gutcaits
Aleksandrs Gutcaits
Research Infrastructure and Technology Support Center, Riga Technical University
Verified email at rtu.lv
Title
Cited by
Cited by
Year
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept
A Rummel, T Eichner, T Weil, T Karnath, A Gutcaits, S Mahrhold, ...
Proceedings of the National Academy of Sciences 104 (1), 359-364, 2007
1992007
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges
I Kufareva, V Katritch, RC Stevens, R Abagyan
Structure 22 (8), 1120-1139, 2014
1752014
Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions
M Lapinsh, P Prusis, A Gutcaits, T Lundstedt, JES Wikberg
Biochimica et Biophysica Acta (BBA)-General Subjects 1525 (1-2), 180-190, 2001
1542001
Classification of G‐protein coupled receptors by alignment‐independent extraction of principal chemical properties of primary amino acid sequences
M Lapinsh, A Gutcaits, P Prusis, C Post, T Lundstedt, JES Wikberg
Protein Science 11 (4), 795-805, 2002
1322002
Mildronate: an antiischemic drug for neurological indications
N Sjakste, A Gutcaits, I Kalvinsh
CNS drug reviews 11 (2), 151-168, 2005
1212005
Quinazolines and 1, 2, 4‐Benzothiadiazine 1, 1‐Dioxides. Part 8. Synthesis and Pharmacological Evaluation of Tricyclic Fused Quinazolines and 1, 2, 4‐Benzothiadiazine 1, 1 …
JW CHERN, PL TAO, KC WANG, A GUTCAIT, SW LIU, MH YEN, ...
ChemInform 29 (49), no-no, 1998
118*1998
Positive and negative modulation of group I metabotropic glutamate receptors
M Vanejevs, C Jatzke, S Renner, S Müller, M Hechenberger, T Bauer, ...
Journal of medicinal chemistry 51 (3), 634-647, 2008
612008
Studies on Quinazolines. Part 6. Asymmetric Synthesis of (S)‐(+)‐and (R)‐(‐)‐3‐((4‐(2‐Methoxyphenyl) piperazin‐1‐yl) methyl)‐5‐methylthio‐2, 3‐dihydroimidazo (1, 2‐c) quinazolines.
A GUTCAIT, KC WANG, HW LIU, JW CHERN
ChemInform 27 (42), no-no, 1996
41*1996
Carrier for targeting nerve cells
A Rummel, T Weil, A Gutcaits
US Patent 8,481,040, 2013
162013
Allosteric modulation of family 3 GPCRs
T Noeske, A Gutcaits, CG Parsons, T Weil
QSAR & Combinatorial Science 25 (2), 134-146, 2006
162006
Hypothetical gamma-butyrobetaine esterase-dependent signal transduction system: possible link to mildronate action
I Kalvinsh, A Gutcaits, L Bagdoniene, D Labeikyte, P Trapencieris, ...
Med Hypotheses Res 3, 803-12, 2006
162006
Substituted pyrazolo [1, 5-a] pyrimidines as metabotropic glutamate receptor modulators
W Danysz, A Dekundy, M Hechenberger, M Henrich, C Jatzke, J Nagel, ...
US Patent 7,947,689, 2011
92011
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
W Danysz, A Dekundy, M Hechenberger, M Henrich, C Jatzke, J Nagel, ...
EP Patent 2,295,439, 2011
9*2011
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
W Danysz, A Dekundy, M Hechenberger, M Henrich, C Jatzke, J Nagel, ...
EP Patent 2,054,416, 2011
9*2011
Tightly bound to DNA proteins: Possible universal substrates for intranuclear processes
N Sjakste, K Bielskiene, L Bagdoniene, D Labeikyte, A Gutcaits, ...
Gene, 2011
82011
Proteins tightly bound to DNA: new data and old problems
N Sjakste, L Bagdoniene, A Gutcaits, D Labeikyte, K Bielskiene, I Trapina, ...
Biochemistry (Moscow) 75 (10), 1240-1251, 2010
82010
CARRIER FOR TARGETING NERVE CELLS
A RUMMEL, T WEIL, A GUTCAITS
WO Patent WO/2006/114,308, 2006
8*2006
Carrier for targeting nerve cells
A Rummel, T Weil, A Gutcaits
US Patent 10,266,816, 2019
72019
Synthesis of 2, 3-Dihydroimidazo [1, 2-a] pyridines from 1, 3-Diketones
E Suloeva, M Yure, E Gudriniece, M Petrova, A Gutcaits
Chemistry of Heterocyclic Compounds 37 (7), 872-875, 2001
72001
Carrier for targeting nerve cells
A Rummel, T Weil, A Gutcaits
US Patent 9,650,622, 2017
62017
The system can't perform the operation now. Try again later.
Articles 1–20